Role of coagulase in a murine model of hematogenous pulmonary infection induced by intravenous injection of Staphylococcus aureus enmeshed in agar beads

Infection and Immunity

Volumn 65, Issue 2, 1997, Pages 466-471

  Sawai, Toyomitsu ^a   Tomono, Kazunori ^a   Yanagihara, Katsunori ^a   Yamamoto, Yoshihiro ^a   Kaku, Mitsuo ^a   Hirakata, Youichi ^a   Koga, Hironobu ^a   Tashiro, Takayoshi ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COAGULASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; BACTERIUM; BACTERIUM COLONY; CONTROLLED STUDY; INFLAMMATORY CELL; LUNG ABSCESS; LUNG CLEARANCE; LUNG INFECTION; MALE; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0031034572     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.2.466-471.1997     Document Type: Article

References (29)

1. Baddour, L. M., M. M. Tayidi, E. Walker, D. McDevitt, and T. J. Foster. 1994. Virulence of coagulase-deficient mutants of Staphylococcus aureus in experimental endocarditis. J. Med. Microbiol. 41:259-263.
2. Boden, M. K., and J. I. Flock. 1989. Fibrinogen-binding protein/clumping factor from Staphylococcus aureus. Infect. Immun. 57:2358-2363.
3. Cash, H. A., D. E. Woods, D. McCullough, W. G. Johanson, and J. A. Bass. 1979. A rat model of chronic respiratory infection with Pseudomonas aeruginosa. Am. Rev. Respir. Dis. 119:453-459.
4. Cawdery, M., W. D. Foster, B. C. Hawgood, and C. Taylor. 1969. The role of coagulase in the defense of Staphylococcus aureus against phagocytosis. Br. J. Exp. Pathol. 50:408-412.
5. DeMaria, T. F., and F. A. Kapral. 1978. Pulmonary infection of mice with Staphylococcus aureus. Infect. Immun. 21:114-123.
6. Espersen, K., I. Clemmensen, and V. Barkholt. 1985. Isolation of Staphylococcus aureus clumping factor. Infect. Immun. 49:1514-1523.
7. Esposito, A. L., and J. E. Pennington. 1983. Effect of aging on antibacterial mechanisms in experimental pneumonia. Am. Rev. Respir. Dis. 128:662-667.
8. Esposito, A. L., L. A. Quinn, E. C. Lucey, and G. Snider. 1987. Effect of the elastase inhibitor, eglinc, on antibacterial mechanisms in experimental pneumonia. Am. Rev. Respir. Dis. 135:676-681.
9. Goldstein, E., W. Lippert, and D. Warshauer. 1974. Pulmonary alveolar macrophage. Defence against bacterial infection of the lung. J. Clin. Invest. 54:519-528.
10. Green, G. M., and E. H. Kass. 1964. The role of the alveolar macrophage in the clearance of bacteria from the lung. J. Exp. Med. 119:167-175.
11. Gross, G. N., S. R. Rehm, and A. K. Pierce. 1978. The effect of complement on lung clearance of bacteria. J. Clin. Invest. 57:373-378.
12. Haraldsson, I., and P. Jonsson. 1984. Histopathology and pathogenesis of mouse mastitis induced with Staphylococcus aureus. J. Comp. Pathol. 94:183-196.
13. Hasegawa, N., and C. L. San Clemente. 1978. Virulence and immunity of Staphylococcus aureus BB and certain deficient mutants. Infect. Immun. 22:473-479.
14. Hemker, H. C., B. M. Bass, and A. D. Muller. 1975. Activation of a proenzyme by a stoichiometric reaction with another protein. The reaction between prothrombin and staphylocoagulase. Biochim. Biophys. Acta 379: 180-188.
15. Jonsson, P., M. Lindberg, I. Haraldsson, and T. Waström. 1985. Virulence of Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, coagulase, and protein A as possible virulence determinants with protoplast fusion and gene cloning. Infect. Immun. 49:765-769.
16. Jordens, J. Z., G. J. Duckworth, and R. J. Williams. 1989. Production of "virulence factors" by "epidermic" methicillin-resistant Staphylococcus aureus in vitro. J. Med. Microbiol. 30:245-252.
17. Kawabata, S., T. Morita, S. Iwanaga, and H. Igarashi. 1985. Enzymatic properties of staphylothrombin, an active molecular complex formed between staphylocoagulase and human prothrombin. J. Biochem. 98:1603-1614.
18. Louria, D. B., T. Hensle, and J. Rose. 1967. The major medical complications of heroin addiction. Ann. Intern. Med. 67:1-22.
19. Masuda, S. 1983. An efficient method for the isolation of a mutant with an extremely low producibility of coagulase from a Staphylococcus aureus strain. Microbiol. Immunol. 27:801-805.
20. McDevitt, D., P. Vaudaux, and T. J. Foster. 1992. Genetic evidence that bound coagulase of Staphylococcus aureus is not clumping factor. Infect. Immun. 60:1514-1523.
21. Moreillon, P., J. M. Entenza, P. Francioli, D. McDevitt, T. J. Foster, P. Francois, and P. Vaudaux. 1995. Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis. Infect. Immun. 63:4738-1743.
22. Musher, D. M., and S. O. McKenzie. 1977. Infections due to Staphylococcus aureus. Medicine 56:383-409.
23. Naraqi, S., and G. McDonnell. 1981. Hematogenous staphylococcal pneumonia secondary to soft tissue infection. Chest 79:173-175.
24. Nugent, K. M., and E. L. Pesanti. 1982. Nonphagocytic clearance of Staphylococcus aureus from murine lungs. Infect. Immun. 36:1185-1191.
25. Nugent, K. M., and E. L. Pesanti. 1982. Staphylococcal clearance and pulmonary macrophage function during influenza infection. Infect. Immun. 38:1225-1262.
26. Phonimdaeng, P., M. O'Reilly, P. Nowlan, A. J. Bramley, and T. J. Foster. 1990. The coagulase of Staphylococcus aureus 8325-4. Sequence analysis and virulence of site-specific coagulase-deficient mutants. Mol. Microbiol. 4:393-404.
27. Seki, K., M. Ogasawara, J. Sakurada, M. Murai, and S. Masuda. 1989. Altered virulence of a pleiotropic Staphylococcus aureus mutant with low producibility of coagulase and other factors in mice. Microbiol. Immunol. 33:981-990.
28. Tuazon, C. U., and J. N. Sheagren. 1974. Increased rate of Staphylococcus aureus among narcotic addicts. J. Infect. Dis. 129:725-727.
29. van de Vijver, J. C. M., M. M. Van es-Boon, and M. F. Michel. 1975. A study of virulence factors with induced mutants of Staphylococcus aureus. J. Med. Microbiol. 8:279-287.